{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:08:06Z","timestamp":1793470086032,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ygyno.2019.09.014","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T08:05:12Z","timestamp":1573286712000},"page":"169-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["A prospective clinical cohort study of women at increased risk for endometrial cancer"],"prefix":"10.1016","volume":"156","author":[{"given":"Megan A.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly J.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen A.","family":"Lemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl C.","family":"Podratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Ahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois J.","family":"Mc Guire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon K.","family":"Laughlin-Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie N.","family":"Bakkum-Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.09.014_bib1","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2019.09.014_bib2","series-title":"International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013","author":"Lortet-Tieulent","year":"2017"},{"key":"10.1016\/j.ygyno.2019.09.014_bib3","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-corrected Uterine Corpus Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Incidence of Non-endometrioid Cancers","volume":"37","author":"Clarke","year":"2019","journal-title":"J\u00a0Clin Oncol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib4","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2019.09.014_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2016.12.010","article-title":"Bokhman Redux: endometrial cancer \"types\" in the 21st century","volume":"144","author":"Suarez","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1055-9965.EPI-18-0264","article-title":"Cancer progress and priorities: uterine cancer","volume":"27","author":"Felix","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2019.09.014_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.canep.2013.03.008","article-title":"Recent changes in endometrial cancer trends among menopausal-age U.S. women","volume":"37","author":"Wartko","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ygyno.2019.09.014_bib8","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ijc.31961","article-title":"Risk factors for endometrial cancer: an umbrella review of the literature","volume":"145","author":"Raglan","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.09.014_bib10","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1200\/JCO.2016.69.4638","article-title":"Addressing the role of obesity in endometrial cancer risk, prevention, and treatment","volume":"34","author":"Onstad","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(15)00212-0","article-title":"Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies","volume":"16","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-43139-0_1","article-title":"Epidemiology of endometrial carcinoma: etiologic importance of hormonal and metabolic influences","volume":"943","author":"Felix","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.ejca.2014.02.020","article-title":"Trends in corpus uteri cancer mortality in member states of the European Union","volume":"50","author":"Weiderpass","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2019.09.014_bib14","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2019.09.014_bib15","unstructured":"UK CR. Uterine Cancer Statistics, vol. vol. 2018: Cancer Research UK.."},{"key":"10.1016\/j.ygyno.2019.09.014_bib16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jamainternmed.2018.2820","article-title":"Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis","volume":"178","author":"Clarke","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ygyno.2019.09.014_bib17","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/jamainternmed.2018.2819","article-title":"Opportunities for early detection of endometrial cancer in women with postmenopausal bleeding","volume":"178","author":"Matteson","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ygyno.2019.09.014_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2019.09.014_bib19","doi-asserted-by":"crossref","first-page":"e1001492","DOI":"10.1371\/journal.pmed.1001492","article-title":"Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies","volume":"10","author":"Pfeiffer","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.ygyno.2019.09.014_bib20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/ijc.30560","article-title":"Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort","volume":"140","author":"Fortner","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.09.014_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2015.01.552","article-title":"Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons","volume":"137","author":"Bakkum-Gamez","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib22","doi-asserted-by":"crossref","first-page":"167ra4","DOI":"10.1126\/scitranslmed.3004952","article-title":"Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers","volume":"5","author":"Kinde","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ygyno.2019.09.014_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8793","article-title":"Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ygyno.2019.09.014_bib24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/1055-9965.882.13.5","article-title":"Methylated DNA collected by tampons--a new tool to detect endometrial cancer","volume":"13","author":"Fiegl","year":"2004","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2019.09.014_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.23636","article-title":"Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study","volume":"114","author":"Kipp","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2019.09.014_bib26","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/ijc.28843","article-title":"Discovery and validation of methylation markers for endometrial cancer","volume":"135","author":"Wentzensen","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.09.014_bib27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1200\/JCO.2009.24.1315","article-title":"Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia","volume":"28","author":"Lacey","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamaoncol.2017.4942","article-title":"Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers","volume":"4","author":"Michels","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ygyno.2019.09.014_bib30","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/aje\/kwx388","article-title":"Oral contraceptive use and risks of cancer in the NIH-AARP diet and Health study","volume":"187","author":"Michels","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2019.09.014_bib31","doi-asserted-by":"crossref","first-page":"g6356","DOI":"10.1136\/bmj.g6356","article-title":"Oral contraceptive use and mortality after 36 years of follow-up in the Nurses\u2019 Health Study: prospective cohort study","volume":"349","author":"Charlton","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2019.09.014_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ijc.27623","article-title":"Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?","volume":"132","author":"Trabert","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2019.09.014_bib33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/IGC.0b013e31820c4cd6","article-title":"Estimating the risk of endometrial cancer in symptomatic postmenopausal women: a novel clinical prediction model based on patients\u2019 characteristics","volume":"21","author":"Burbos","year":"2011","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:45:23Z","timestamp":1758771923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819315343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0090825819315343"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective clinical cohort study of women at increased risk for endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}